Centiva Capital, LP Abbott Laboratories Call Options Transaction History

Centiva Capital, LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $1.07 Million - $1.26 Million	10,700 New	10,700 $1.22 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $3.12 Million - $3.45 Million	28,500 Added 1900.0%	30,000 $3.41 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $820,729 - $1 Million	-9,100 Reduced 85.85%	1,500 $165,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $534,968 - $641,872	5,600 Added 112.0%	10,600 $1.03 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $503,900 - $561,450	5,000 New	5,000 $545,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $967,600 - $1.12 Million	10,000 New	10,000 $968,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $854,352 - $1.25 Million	-13,600 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $785,100 - $874,000	10,000 Added 277.78%	13,600 $1.18 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $5.93 Million - $6.42 Million	-72,400 Reduced 95.26%	3,600 $301,000
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $5.54 Million - $6.46 Million	76,000 New	76,000 $6.39 Million

3,204

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $219B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.